Kelly Lisa 4
4 · VERTEX PHARMACEUTICALS INC / MA · Filed Nov 19, 2012
Insider Transaction Report
Form 4
Kelly Lisa
SVP, Human Resources
Transactions
- Sale
Common Stock
2012-11-15$40.59/sh−355$14,409→ 17,249 total - Sale
Common Stock
2012-11-16$41.28/sh−2,033$83,922→ 15,216 total
Holdings
- 1,959(indirect: By 401(k))
Common Stock
Footnotes (4)
- [F1]Transaction made pursuant to Ms. Kelly-Croswell's company approved trading plan under Rule 10b5-1.
- [F2]Open market sales reported on this line occurred at a weighted average price of $40.59 (range $40.34 to $41.23).
- [F3]Ms. Kelly-Croswell undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
- [F4]Open market sales reported on this line occurred at a weighted average price of $41.28 (range $41.01 to $41.82).